v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net income $ 58,316 $ 36,672
Adjustments to reconcile net income to net cash provided by operating activities:     
Depreciation 8,071 6,774
Amortization of intangible assets 0 116
Deferred income taxes 41 1,048
Net credit loss reversals (24) (1,729)
Amortization of debt issuance costs 394 394
Stock-based compensation costs 2,004 1,747
Net unrealized losses on investments 247 117
Gain on sale of assets (1,970) (2,371)
Equity in earnings of unconsolidated affiliates, net of distributions 7,203 (2,743)
Changes in operating assets and liabilities:    
Receivables (11,711) (1,052)
Contract assets (2,291) (54,861)
Inventories, net (2,707) (3,663)
Other current assets 14,713 (4,464)
Accounts payable 33,539 43,625
Contract liabilities, net 39,848 (20,733)
Other current liabilities (4,640) 7,579
Other noncurrent changes 2,642 672
Net cash provided by operating activities 143,675 7,128
Investing activities:    
Capital expenditures (15,470) (18,539)
Net proceeds from sale or disposition of property, plant and equipment 3,719 3,310
Proceeds from insurance contracts 0 2,174
Investments (2,550) (1,766)
Net cash used in investing activities (14,301) (14,821)
Financing activities:    
Repayment of long-term debt (3,750) (3,750)
Tax withholding on stock-based compensation (2,768) (588)
Net cash used in financing activities (6,518) (4,338)
Increase (decrease) in cash, cash equivalents and restricted cash 122,856 (12,031)
Cash, cash equivalents and restricted cash - beginning of period 170,500 86,012
Cash, cash equivalents and restricted cash - end of period 293,356 73,981
Interest paid 4,291 4,171
Income taxes paid, net 205 1,161
Purchases of property, plant and equipment included in Accounts payable $ 282 $ 1,035